Uptal Patel is a Nephrology physician affiliated with Biogen. OpenAlex indexes 247 publications with 13,551 citations (h-index 56); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4101 N Roxboro St
Durham, NC 277042121
Telephone
919-684-8111Registry record last updated 8 Jul 2007.
Clinical trials
- Integrated Population Program for Diabetic Kidney Disease
Sponsor: Duke University
- Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Sponsor: Uptal Patel
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20231 payment
- Boston Scientific CorporationProgram year20221 payment
- BOSTON SCIENTIFIC CORPORATIONProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2006–2016 per NIH RePORTER. The latest:
- Multi-factorial Intervention to Slow Progression of Diabetic Kidney Disease
Duke University
FY2015$682,611R01DK093938
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
New England Journal of Medicine
2024 - Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney
Journal of the American Society of Nephrology
2021 - International consensus definitions of clinical trial outcomes for kidney failure: 2020
Kidney International
2020 - Effects of Selonsertib in Patients with Diabetic Kidney Disease
Journal of the American Society of Nephrology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”